Hims & Hers Health Inc. diskutieren
Hims & Hers Health Inc.
WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Aktie / ? /
23,03 €
14,92 %
Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its price target raised by analysts at Bank of America Corporation from $28.00 to $32.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at BTIG Research from $85.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Bank of America Corporation from $26.00 to $21.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $16.50. They now have a "sell" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Citigroup Inc. from $16.50 to $13.25. They now have a "sell" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (HIMS) was upgraded by Needham & Company LLC from "hold" to "buy". They now have a $30.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health (HIMS) had its price target raised by Barclays PLC from $25.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in StoneCo Ltd diskutieren